(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 32.13 | 39.55 | -18.76 | 103.17 | 99.90 | 3.27 | 143.51 | 101.72 | 41.08 |
| Other Income | 0.15 | 0.34 | -55.88 | 0.25 | 0.66 | -62.12 | 0.00 | 0.00 | 0.00 |
| PBIDT | -0.74 | 0.42 | -276.19 | 5.67 | 3.85 | 47.27 | 5.09 | 3.58 | 42.18 |
| Interest | 0.03 | 0.03 | 0.00 | 0.11 | 0.13 | -15.38 | 1.32 | 1.73 | -23.70 |
| PBDT | -0.77 | 0.39 | -297.44 | 5.56 | 3.72 | 49.46 | 3.77 | 1.85 | 103.78 |
| Depreciation | 0.18 | 0.19 | -5.26 | 0.57 | 0.59 | -3.39 | 0.76 | 0.81 | -6.17 |
| PBT | -0.95 | 0.20 | -575.00 | 4.99 | 3.13 | 59.42 | 3.01 | 1.04 | 189.42 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -0.95 | 0.20 | -575.00 | 4.99 | 3.13 | 59.42 | 2.54 | 1.04 | 144.23 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | -2.30 | 1.06 | -316.88 | 5.50 | 3.85 | 42.60 | 3.55 | 3.52 | 0.78 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: